All content for Future Science Group is the property of Taylor & Francis Group and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Trends, tools and transformation: the evolution of flow cytometry in bioanalysis by Taylor & Francis Group
The new frontier: assessing efficacy and safety of CGTs using biomarkers
Future Science Group
24 minutes 21 seconds
1 year ago
The new frontier: assessing efficacy and safety of CGTs using biomarkers
In the sixth episode of The new frontier podcast, we're joined by Catherine Vrentas, Life Sciences Lead at Booz Allen Hamilton (VA, USA). Cathy explains how biomarkers can be used to predict the therapeutic outcome and efficacy of CGTs and the biomarkers in particular that have shown strong predictive value. We delve into the common challenges of working with biomarkers in CGTs and how biomarker kits can be adapted for CGT work.
Future Science Group
Trends, tools and transformation: the evolution of flow cytometry in bioanalysis by Taylor & Francis Group
